B2DB — Who said what, where, and when

Ludwin Ley

Boehringer Ingelheim Pharma GmbH

Ludwin Ley is listed as Boehringer Ingelheim Pharma GmbH. Ludwin spoke at DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) in November 2026 (speaker, “Neurologie trifft Unternehmen”).

Compiled from published conference agendas; not yet confirmed by Ludwin. Is this you? Claim this profile.

Sessions at 1 conference

DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) 4 November 2026 – 7 November 2026